CANCER INTELLIGENCE CARE SYSTEMS, INC.

National Cancer Center to Initiate Basket Trial of BNCT for Thoracic Malignancies

9 months ago

• The National Cancer Center Japan will conduct a Phase I/II basket trial of Boron Neutron Capture Therapy (BNCT) for unresectable and recurrent thoracic malignant solid tumors. • This trial is the first of its kind to evaluate BNCT across multiple thoracic cancer types, aiming to expedite development by grouping cancers with shared organs at risk. • The study will assess the safety and efficacy of BNCT, along with the utility of [18F]F-BPA PET imaging in determining patient suitability for BNCT. • The collaboration involves Sumitomo Heavy Industries, STELLA PHARMA CORPORATION, and Cancer Intelligence Care Systems, with the trial period extending until October 2028.